ClinicalTrials.gg
CompletedNCT07781254VR-PEDUpdated Aug 24, 2026

Immersive Virtual Reality for Pain and Dental Anxiety During Pediatric Restorative Treatment

An interventional study of Immersive Virtual Reality in Dental Anxiety in Children, Dental Pain and Virtual Reality, sponsored by University of Gaziantep. Completed at 1 site in Turkey (Türkiye). Open to participants aged 8 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by University of Gaziantep · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled May 2025, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
8 Years to 12 Years
Sex
All
01

Study summary

This study evaluated whether immersive virtual reality (VR) can help reduce pain and dental fear and improve behavioral cooperation in children undergoing restorative dental treatment. Children aged 8-12 years who required treatment of primary molars were randomly assigned to either a VR group or a control group. Children in the VR group watched an age-appropriate animated video through a VR headset during local anesthesia and dental treatment, while children in the control group received routine dental treatment without VR. Pain, dental anxiety, dental fear, behavioral cooperation, emotional responses, physiological measurements, treatment duration, and parent and clinician satisfaction were assessed and compared between the two groups.

Read the detailed description

This single-center, two-arm, parallel-group randomized controlled clinical trial evaluated the effects of immersive virtual reality (VR) distraction during restorative dental treatment in children aged 8-12 years.

Children requiring restorative treatment of mandibular second primary molars with occlusal carious lesions classified as ICDAS II codes 2-4 were eligible for participation. Eligible children were randomly assigned in a 1:1 ratio to either an immersive VR group or a control group. Randomization was performed using a computer-generated sequence, with allocation concealed in sequentially numbered, opaque, sealed envelopes.

Children in the VR group used an immersive VR headset during the dental procedure and watched the same age-appropriate animated video throughout treatment. The headset was placed approximately one minute before administration of local anesthesia and remained in place until completion of the restorative procedure. Children in the control group received routine restorative dental treatment without a distraction intervention.

All dental procedures were performed by the same calibrated pediatric dentist according to a standardized clinical protocol. Local anesthesia was administered using an inferior alveolar nerve block with 1.8 mL of 2% lidocaine through a 30-gauge dental needle. The restorative procedure was performed on mandibular second primary molars and lasted approximately 10-15 minutes.

The primary outcome was children's pain perception, assessed using the Wong-Baker Faces Pain Rating Scale. Secondary outcomes included behavioral cooperation, dental anxiety, dental fear, emotional responses, physiological parameters, parent and clinician satisfaction, and treatment duration.

Pain was assessed during and immediately after treatment. Behavioral cooperation and physiological parameters were assessed before, during, and after treatment. Dental anxiety and emotional responses were assessed before and after treatment, while dental fear was evaluated using a validated questionnaire. Parent and clinician satisfaction were assessed immediately after treatment.

The study was conducted in accordance with the ethical principles of the Declaration of Helsinki. The study protocol received approval from the Sanko University Clinical Research Ethics Committee (KAEK-028-1). Written informed consent was obtained from the parents or legal guardians, and verbal assent was obtained from the participating children.

02

Conditions studied

  • Dental Anxiety in Children
  • Dental Pain
  • Virtual Reality
  • Distraction
  • Dental Caries

Keywords

  • Virtual Reality
  • Pediatric dentistry
  • Dental fear
  • Pain perception
  • Behavior guidance
  • child
03

In context

Toothache

142 studies on the registry are indexed under Toothache; 28 are open to participants now.

This study's enrollment of 70 is below the median of 84 across 123 interventional studies indexed under Toothache.

Browse Toothache studies →

Lead sponsor

University of Gaziantep is the lead sponsor of 105 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Children aged 8-12 years. Children requiring dental treatment under local anesthesia. Children who are able to understand and follow the study instructions. Children whose parents/legal guardians provide written . Children who provide age-appropriate assent to participate.

Exclusion criteria

Exclusion Criteria:

Children with systemic, neurological, psychiatric, cognitive, or developmental conditions that may affect anxiety or pain assessment.

Children with visual or auditory impairments that prevent appropriate use of the VR system or communication with the investigator.

Children with a history of seizures or other conditions for which VR use is .

Children who refuse to participate or whose parents/legal guardians withdraw consent.

Children who are unable to complete the dental treatment or study assessments.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Virtual Reality Group

    Participants received immersive virtual reality-based audiovisual distraction during standardized restorative dental treatment. The VR headset was fitted approximately 1 minute before local anesthesia and remained in place throughout the restorative procedure. Participants watched a standardized age-appropriate animated video (Pırıl) for approximately 10-15 minutes.

    Behavioral: Immersive Virtual Reality

  • No intervention
    Control Group

    Participants received routine restorative dental treatment without a distraction intervention. Local anesthesia and restorative procedures were performed according to the same standardized clinical protocol used for the virtual reality group.

Interventions

  • BehavioralImmersive Virtual Reality

    Immersive virtual reality-based audiovisual distraction using a standardized, age-appropriate animated video during restorative dental treatment.

06

What researchers measure

Primary outcomes

  1. Pain Perception

    Pain perception was assessed using the Wong-Baker Faces Pain Rating Scale (WBFPRS), with higher scores indicating greater pain intensity.

    Time frame: During treatment (T1) and immediately after completion of the restorative procedure (T2)

07

Study locations

1 site
  • Gaziantep University Faculty of Dentistry
    Gaziantep, 27310, Turkey (Türkiye)
08

References and documents

Publications

  • Wu W, Le May S, Hung N, Fortin O, Genest C, Francoeur M, Guingo E, St-Arneault K, Sylfra A, Vu AK, Carmel J, Lessard L, Cara-Slavich S, De Koven K, Paquette J, Hoffman H, Asselin ME. Effects of a Virtual Reality Game on Children's Anxiety During Dental Procedures (VR-TOOTH): Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2023 Nov 10;12:e49956. doi: 10.2196/49956. PubMed 37948113 ↗
  • Kasimoglu Y, Alpaycetin E, Ince G, Tuna Ince EB. Reduction of Dental Anxiety in Children Using Virtual Reality: A Randomised Controlled Trial. Eur J Paediatr Dent. 2025 Sep 1;26(3):185-191. doi: 10.23804/ejpd.2024.2109. Epub 2024 Oct 1. PubMed 39465519 ↗
  • Barros Padilha DX, Veiga NJ, Mello-Moura ACV, Nunes Correia P. Virtual reality and behaviour management in paediatric dentistry: a systematic review. BMC Oral Health. 2023 Dec 12;23(1):995. doi: 10.1186/s12903-023-03595-7. PubMed 38087294 ↗
  • Yan X, Yan Y, Cao M, Xie W, O'Connor S, Lee JJ, Ho MH. Effectiveness of virtual reality distraction interventions to reduce dental anxiety in paediatric patients: A systematic review and meta-analysis. J Dent. 2023 May;132:104455. doi: 10.1016/j.jdent.2023.104455. Epub 2023 Feb 24. PubMed 36842625 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2025 to primary completion in Aug 2025, 3 months.

Of 44 non-industry interventional studies with no phase under Toothache, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's 3 months is below that.

Counting every sponsor, half of 45 studies reached it within 5 months; a quarter within 3 and three quarters within 12.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 19, 2026
First posted
Aug 24, 2026
StartActual
May 20, 2025
Primary completionActual
Aug 28, 2025
CompletionActual
Aug 28, 2025
Last update
Aug 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07781254
Responsible party
Zehra Güner (Assistant Professor, University of Gaziantep) — Principal investigator
First posted
Aug 24, 2026
Start date
May 20, 2025
Primary completion
Aug 28, 2025
Completion
Aug 28, 2025
Last update
Aug 24, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion